Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Paintaud

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Medecine Sciences : M/S|December 29, 2009
[Pharmacokinetics (PK) of mAbs]Gilles Paintaud
Expert Opinion on Biological Therapy|September 29, 2005
Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteinsDavid Ternant, Gilles Paintaud
Therapie|July 10, 2016
Biotherapies: Are they Just Like any Other Drugs?Gilles Paintaud, Dominique Tonelli, Eric Postaire, et al.
Therapie|September 14, 2004
[Biomarkers and pharmacokinetic-pharmacodynamic studies of immunosuppressive agents]Gilles Paintaud, Maud Bénéton, Hervé Watier
Therapie|July 10, 2016
[Not Available]Gilles Paintaud, Dominique Tonelli, Eric Postaire, et al.
Therapie|November 1, 2012
Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of SafetyGilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie|November 1, 2012
[In Process Citation]Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie|September 7, 2007
Biotherapies: are they just like any other drugs?Gilles Paintaud, Dominique Tonelli, Eric Postaire, et al.
Therapie|July 10, 2016
[Not Available]Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
JAMA|September 21, 2021
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory DiseasesOlivier Le Tilly, Gilles Paintaud, David Ternant
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Medecine Sciences : M/S|December 29, 2009
[Pharmacokinetics (PK) of mAbs]Gilles Paintaud
Expert Opinion on Biological Therapy|September 29, 2005
Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteinsDavid Ternant, Gilles Paintaud
Therapie|July 10, 2016
Biotherapies: Are they Just Like any Other Drugs?Gilles Paintaud, Dominique Tonelli, Eric Postaire, et al.
Therapie|September 14, 2004
[Biomarkers and pharmacokinetic-pharmacodynamic studies of immunosuppressive agents]Gilles Paintaud, Maud Bénéton, Hervé Watier
Therapie|July 10, 2016
[Not Available]Gilles Paintaud, Dominique Tonelli, Eric Postaire, et al.
Therapie|November 1, 2012
Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of SafetyGilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie|November 1, 2012
[In Process Citation]Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Therapie|September 7, 2007
Biotherapies: are they just like any other drugs?Gilles Paintaud, Dominique Tonelli, Eric Postaire, et al.
Therapie|July 10, 2016
[Not Available]Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.
JAMA|September 21, 2021
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory DiseasesOlivier Le Tilly, Gilles Paintaud, David Ternant
Pageof 16